ACORQ Financial Statements

Balance sheet, income statement, cash flow, and dividends for Acorda Therapeutics Inc (ACORQ).


$18.74M Market Cap.

As of 04/02/2024 5:00 PM ET (MRY) • Disclaimer

ACORQ Market Cap. (MRY)


ACORQ Shares Outstanding (MRY)


ACORQ Assets (MRY)


Total Assets

$108.53M

Total Liabilities

$266.48M

Total Investments

$0

ACORQ Income (MRY)


Revenue

$117.63M

Net Income

-$252.85M

Operating Expense

$376.94M

ACORQ Cash Flow (MRY)


CF Operations

-$13.98M

CF Investing

-$264.00K

CF Financing

$0

ACORQ Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

0%

0%

-

2019

$0

0%

-

0%

-

ACORQ Balance Sheet (MRY)


Metric

2023

2022

2021

2020

Total Assets

$108,525,000 (-72.57%)

$395,595,000 (-13.15%)

$455,470,000 (-28.01%)

$632,680,000 (-20.89%)

Assets Current

$74,794,000 (-8.92%)

$82,115,000 (-19.62%)

$102,157,000 (-53.85%)

$221,335,000 (10.06%)

Assets Non-Current

$33,731,000 (-89.24%)

$313,480,000 (-11.27%)

$353,313,000 (-14.11%)

$411,345,000 (-31.28%)

Goodwill & Intangible Assets

$22,987,000 (-92.47%)

$305,087,000 (-9.19%)

$335,980,000 (-8.45%)

$366,981,000 (-8.79%)

Shareholders Equity

-$157,956,000 (-268.72%)

$93,622,000 (-38.05%)

$151,137,000 (-36.49%)

$237,955,000 (-23.44%)

Property Plant & Equipment Net

$6,300,000 (-20.15%)

$7,890,000 (-29.13%)

$11,133,000 (-56.75%)

$25,744,000 (-84.49%)

Cash & Equivalents

$30,615,000 (-31.47%)

$44,675,000 (-31.50%)

$65,223,000 (-36.61%)

$102,895,000 (-2.18%)

Accumulated Other Comprehensive Income

$1,425,000 (126.91%)

$628,000 (161.75%)

-$1,017,000 (63.72%)

-$2,803,000 (-139.78%)

Deferred Revenue

$227,000 (-40.89%)

$384,000 (0%)

$0 (0%)

$0 (0%)

Total Investments

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$16,155,000 (26.69%)

$12,752,000 (-31.25%)

$18,548,000 (-35.32%)

$28,677,000 (13.70%)

Trade & Non-Trade Receivables

$17,298,000 (24.75%)

$13,866,000 (-18.44%)

$17,002,000 (-15.80%)

$20,193,000 (-8.56%)

Trade & Non-Trade Payables

$13,373,000 (36.33%)

$9,809,000 (-9.55%)

$10,845,000 (-10.78%)

$12,155,000 (-53.71%)

Accumulated Retained Earnings (Deficit)

-$1,189,127,000 (-27.01%)

-$936,273,000 (-7.57%)

-$870,357,000 (-13.56%)

-$766,403,000 (-14.94%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$44,202,000 (217.32%)

$13,930,000 (-27.13%)

$19,116,000 (99.52%)

Total Debt

$190,897,000 (10.40%)

$172,917,000 (-9.44%)

$190,942,000 (-26.55%)

$259,949,000 (4.14%)

Debt Current

$187,731,000 (12050.87%)

$1,545,000 (-81.13%)

$8,186,000 (-89.31%)

$76,575,000 (817.18%)

Debt Non-Current

$3,166,000 (-98.15%)

$171,372,000 (-6.23%)

$182,756,000 (-0.34%)

$183,374,000 (-23.99%)

Total Liabilities

$266,481,000 (-11.75%)

$301,973,000 (-0.78%)

$304,333,000 (-22.90%)

$394,725,000 (-19.26%)

Liabilities Current

$227,773,000 (500.19%)

$37,950,000 (-29.75%)

$54,025,000 (-60.64%)

$137,252,000 (58.88%)

Liabilities Non-Current

$38,708,000 (-85.34%)

$264,023,000 (5.48%)

$250,308,000 (-2.78%)

$257,473,000 (-36.03%)

ACORQ Income Statement (MRY)


Metric

2023

2022

2021

2020

Revenues

$117,633,000 (-0.79%)

$118,566,000 (-8.14%)

$129,071,000 (-15.62%)

$152,967,000 (-20.50%)

Cost of Revenue

$15,283,000 (-49.61%)

$30,332,000 (-25.63%)

$40,787,000 (21.71%)

$33,513,000 (-3.83%)

Selling General & Administrative Expense

$89,698,000 (-15.58%)

$106,256,000 (-14.58%)

$124,399,000 (-18.47%)

$152,576,000 (-20.88%)

Research & Development Expense

$5,152,000 (-11.23%)

$5,804,000 (-44.30%)

$10,420,000 (-54.72%)

$23,012,000 (-61.70%)

Operating Expenses

$376,936,000 (189.35%)

$130,270,000 (-21.33%)

$165,583,000 (-38.30%)

$268,378,000 (-51.74%)

Interest Expense

$31,533,000 (4.41%)

$30,200,000 (0.55%)

$30,035,000 (-1.76%)

$30,574,000 (39.79%)

Income Tax Expense

-$43,167,000 (-240.75%)

$30,669,000 (699.00%)

-$5,120,000 (36.58%)

-$8,073,000 (-529.72%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$252,854,000 (-283.60%)

-$65,916,000 (36.59%)

-$103,954,000 (-4.38%)

-$99,594,000 (63.51%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$252,854,000 (-283.60%)

-$65,916,000 (36.59%)

-$103,954,000 (-4.38%)

-$99,594,000 (63.51%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$252,854,000 (-283.60%)

-$65,916,000 (36.59%)

-$103,954,000 (-4.38%)

-$99,594,000 (63.51%)

Weighted Average Shares

$1,242,000 (26.05%)

$985,350 (85.55%)

$531,050 (31.38%)

$404,200 (1.98%)

Weighted Average Shares Diluted

$1,242,000 (26.05%)

$985,350 (85.55%)

$531,050 (31.38%)

$404,200 (1.98%)

Earning Before Interest & Taxes (EBIT)

-$264,488,000 (-5140.50%)

-$5,047,000 (93.61%)

-$79,039,000 (-2.52%)

-$77,093,000 (69.45%)

Gross Profit

$102,350,000 (16.00%)

$88,234,000 (-0.06%)

$88,284,000 (-26.09%)

$119,454,000 (-24.18%)

Operating Income

-$274,586,000 (-553.22%)

-$42,036,000 (45.62%)

-$77,299,000 (48.10%)

-$148,924,000 (62.64%)

ACORQ Cash Flow Statement (MRY)


Metric

2023

2022

2021

2020

Net Cash Flow from Investing

-$264,000 (-94.12%)

-$136,000 (-100.18%)

$73,778,000 (24.29%)

$59,360,000 (11854.46%)

Net Cash Flow from Financing

$0 (0%)

$0 (0%)

-$69,655,000 (-4075.96%)

-$1,668,000 (97.25%)

Net Cash Flow from Operations

-$13,984,000 (33.17%)

-$20,924,000 (49.40%)

-$41,348,000 (32.22%)

-$61,006,000 (52.40%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$14,060,000 (31.57%)

-$20,548,000 (45.46%)

-$37,672,000 (-1540.77%)

-$2,296,000 (98.79%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$0 (0%)

$0 (0%)

$73,969,000 (16.03%)

$63,750,000 (-29.10%)

Capital Expenditure

-$264,000 (-94.12%)

-$136,000 (17.58%)

-$165,000 (96.24%)

-$4,390,000 (95.15%)

Issuance (Repayment) of Debt Securities

$0 (0%)

$0 (0%)

-$69,655,000 (-4075.96%)

-$1,668,000 (97.24%)

Issuance (Purchase) of Equity Shares

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$188,000 (-63.28%)

$512,000 (214.54%)

-$447,000 (-143.91%)

$1,018,000 (1541.94%)

Share Based Compensation

$478,000 (-67.98%)

$1,493,000 (-50.15%)

$2,995,000 (-63.02%)

$8,100,000 (-43.16%)

Depreciation Amortization & Accretion

$31,600,000 (-3.68%)

$32,809,000 (-3.37%)

$33,953,000 (-17.79%)

$41,298,000 (19.45%)

ACORQ Financial Metrics (MRY)


Metric

2023

2022

2021

2020

Gross Margin

87.00% (16.94%)

74.40% (8.77%)

68.40% (-12.42%)

78.10% (-4.64%)

Profit Margin

-215.00% (-286.69%)

-55.60% (30.93%)

-80.50% (-23.66%)

-65.10% (54.12%)

EBITDA Margin

-198.00% (-946.15%)

23.40% (167.05%)

-34.90% (-49.15%)

-23.40% (79.33%)

Return on Average Equity (ROAE)

-2206.90% (-3121.75%)

-68.50% (-17.29%)

-58.40% (-68.30%)

-34.70% (45.87%)

Return on Average Assets (ROAA)

-83.30% (-411.04%)

-16.30% (21.63%)

-20.80% (-47.52%)

-14.10% (46.99%)

Return on Sales (ROS)

-224.80% (-5127.91%)

-4.30% (92.97%)

-61.20% (-21.43%)

-50.40% (61.59%)

Return on Invested Capital (ROIC)

-179.20% (-6792.31%)

-2.60% (93.78%)

-41.80% (-101.93%)

-20.70% (51.86%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-0.07 (67.83%)

-0.23 (5.74%)

-0.24 (27.38%)

-0.34 (5.62%)

Price to Sales Ratio (P/S)

0.16 (25.20%)

0.13 (-35.53%)

0.2 (-10.05%)

0.22 (-56.55%)

Price to Book Ratio (P/B)

-0.12 (-159.80%)

0.2 (12.43%)

0.18 (27.34%)

0.14 (-55.87%)

Debt to Equity Ratio (D/E)

-1.69 (-152.31%)

3.23 (60.13%)

2.01 (21.40%)

1.66 (5.47%)

Earnings Per Share (EPS)

-203.57 (-204.75%)

-66.8 (65.88%)

-195.8 (20.54%)

-246.4 (64.22%)

Sales Per Share (SPS)

94.71 (-21.29%)

120.33 (-50.49%)

243.05 (-35.78%)

378.44 (-22.04%)

Free Cash Flow Per Share (FCFPS)

-11.47 (46.32%)

-21.37 (72.66%)

-78.17 (51.68%)

-161.79 (70.66%)

Book Value Per Share (BVPS)

-127.18 (-233.85%)

95.01 (-66.61%)

284.6 (-51.66%)

588.71 (-24.93%)

Tangible Assets Book Value Per Share (TABVPS)

68.87 (-25.02%)

91.85 (-59.18%)

225.01 (-65.77%)

657.35 (-34.44%)

Enterprise Value Over EBIT (EV/EBIT)

-1 (97.14%)

-35 (-1650.00%)

-2 (33.33%)

-3 (-200.00%)

Enterprise Value Over EBITDA (EV/EBITDA)

-0.73 (-111.45%)

6.42 (288.16%)

-3.41 (36.87%)

-5.41 (-225.60%)

Asset Turnover

0.39 (32.08%)

0.29 (13.13%)

0.26 (19.35%)

0.22 (16.04%)

Current Ratio

0.33 (-84.84%)

2.16 (14.44%)

1.89 (17.23%)

1.61 (-30.71%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$14,248,000 (32.35%)

-$21,060,000 (49.27%)

-$41,513,000 (36.52%)

-$65,396,000 (70.08%)

Enterprise Value (EV)

$171,248,259 (-3.92%)

$178,231,802 (15.86%)

$153,832,358 (-20.48%)

$193,459,852 (-46.51%)

Earnings Before Tax (EBT)

-$296,021,000 (-739.85%)

-$35,247,000 (67.69%)

-$109,074,000 (-1.31%)

-$107,667,000 (60.74%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$232,888,000 (-938.87%)

$27,762,000 (161.58%)

-$45,086,000 (-25.96%)

-$35,795,000 (83.57%)

Invested Capital

$18,047,000 (-90.02%)

$180,800,000 (-5.43%)

$191,184,000 (-33.04%)

$285,501,000 (-37.31%)

Working Capital

-$152,979,000 (-446.38%)

$44,165,000 (-8.24%)

$48,132,000 (-42.76%)

$84,083,000 (-26.71%)

Tangible Asset Value

$85,538,000 (-5.49%)

$90,508,000 (-24.25%)

$119,490,000 (-55.03%)

$265,699,000 (-33.14%)

Market Capitalization

$18,743,259 (0.45%)

$18,659,802 (-30.30%)

$26,773,358 (-19.11%)

$33,098,852 (-66.22%)

Average Equity

$11,457,250 (-88.09%)

$96,211,000 (-45.98%)

$178,093,000 (-38.00%)

$287,266,250 (-32.55%)

Average Assets

$303,617,750 (-25.00%)

$404,846,000 (-18.91%)

$499,275,750 (-29.31%)

$706,290,500 (-31.28%)

Invested Capital Average

$147,618,750 (-23.33%)

$192,538,000 (1.74%)

$189,248,750 (-49.27%)

$373,025,750 (-36.50%)

Shares

1,242,098 (2.07%)

1,216,891 (117.26%)

560,112 (40.14%)

399,687 (-0.14%)